On January 8, 2020, Zosano Pharma Corporation (the Company') announced the appointment of Christine Matthews as interim chief financial officer. On April 27, 2020, Ms. Matthews was appointed as the permanent chief financial officer and principal financial officer of the Company, effective as of May 1, 2020 (the Effective Date'). He will report to the Chief Executive Officer of the Company.
Zosano Pharma Corporation
Equities
ZSAN
US98979H3012
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+18.44% | 12TCr | |
+15.11% | 11TCr | |
-4.43% | 2.4TCr | |
+2.18% | 2.26TCr | |
-10.09% | 1.82TCr | |
-41.04% | 1.68TCr | |
-12.64% | 1.62TCr | |
+2.45% | 1.34TCr | |
+24.27% | 1.13TCr |